Marshall Aerospace’s medevac system to remain in service
Image courtesy Marshall Aerospace
The system has seen significant recent use supporting Ukrainian wounded soldiers and civilians needing transport to medical facilities across Europe.
SAS recently announced that its long-standing medevac partnership with the Norwegian Armed Forces has been renewed through 2027, with the agreement formalised through the Norwegian Defence Materiel Agency. At the centre of that capability is a specially configured Boeing 737-700 fitted with the role-change aeromedical evacuation solution, enabling the rapid conversion of a commercial passenger aircraft into an airborne medical platform.
When testing concluded in 2010, the system became the first certified role change modification of its kind to be operated by a commercial airline. More than a decade on, it remains an important element of Norway’s strategic aeromedical evacuation capacity and a clear example of enduring engineering value in operational service.
The extension follows several years in which the aircraft and its onboard medical infrastructure have demonstrated their value in supporting demanding real-world missions. Since 2022, the capability has played a central role in transporting thousands of wounded and critically ill patients from Ukraine to hospitals across Europe under the EU Civil Protection Mechanism. In 2024, the same system also played a role in the medical evacuation of King Harald V of Norway from Malaysia.
The continued use of the system through 2027 underlines the strength of the long-standing civil-military partnership behind the capability, as well as the durability of the Marshall/NODIN solution. Developed for a demanding operational need and still supporting lifesaving missions today, it remains a proven and adaptable platform for strategic aeromedical evacuation.
Marshall Aerospace continues to provide support for the capability as required.
